Keyphrases
Multi-institutional
100%
Prognostic Factors
100%
Non-small Cell Lung Cancer (NSCLC)
100%
Drug Therapy
100%
Salvage Surgery
100%
Carcinoembryonic Antigen
33%
Carcinoembryonic Antigen Levels
33%
Overall Survival
22%
5-year Survival
22%
Tyrosine Kinase Inhibitor Therapy
22%
Immune Checkpoint Inhibitors
22%
Tumor
11%
Multivariate Analysis
11%
Molecular Targets
11%
Tyrosine Kinase Inhibitor
11%
Confidence Interval
11%
Progression-free Survival
11%
Segmentectomy
11%
Hazard Ratio
11%
Mortality Rate
11%
Overall Survival Rate
11%
Serious Complications
11%
Lobectomy
11%
Gross Total Resection
11%
Postoperative Complications
11%
Advanced Stage
11%
Primary Lesion
11%
Cytotoxic Agents
11%
Wedge Resection
11%
Retrospective Investigation
11%
Local Progression
11%
Prognosticator
11%
Medicine and Dentistry
Retrospective Study
100%
Prognostic Factor
100%
Drug Therapy
100%
Non Small Cell Lung Cancer
100%
Overall Survival
44%
Carcinoembryonic Antigen
33%
Tyrosine-Kinase Inhibitor
33%
Survival Rate
22%
Immune Checkpoint Inhibitor
22%
Surgery
11%
Multivariate Analysis
11%
Tumor Progression
11%
Prevalence
11%
Progression Free Survival
11%
Segmentectomy
11%
Lobectomy
11%
Mortality Rate
11%
Hazard Ratio
11%
Wedge Resection
11%
Postoperative Complication
11%
Clinical Stage
11%
Cytotoxic Agent
11%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacotherapy
100%
Retrospective Study
100%
Non Small Cell Lung Cancer
100%
Overall Survival
44%
Protein Tyrosine Kinase Inhibitor
33%
Carcinoembryonic Antigen
33%
Survival Rate
22%
Immune Checkpoint Inhibitor
22%
Progression Free Survival
11%
Prevalence
11%
Mortality Rate
11%
Tumor Growth
11%
Postoperative Complication
11%
Cytotoxic Agent
11%